Create an Account
  1. Home
  2. Specialty
  3. Cataract & Refractive

KOL KNOCKOUT™: Cataract Edition | Aligning Patient Preferences and Ocular Characteristics for Optimal IOL Matchmaking - Round 1

KOL KNOCKOUT Cataract Edition Aligning Patient Preferences and Ocular Characteristics for Optimal IOL Matchmaking Round 1
Media formats available:
Details
Presenters

  • Overview

    This popular CME program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Blake K. Williamson, MD, MPH, MS, the first of three rounds featured Zaina Al-Mohtaseb, MD; Michael Greenwood, MD; and Bennett Walton, MD, MBA, as contestants. 

    Dr. Williamson presented complex cataract surgery case studies and each KOL weighed in on their preferred treatment option. Find out who won! 

    This content was captured during a live-virtual symposium. Voting took place during the symposium. There will be two more rounds as well! 

    This activity is supported by an independent educational grant from Alcon.

     

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Explain the importance of understanding patient goals, preferences, and lifestyle before cataract surgery
    • Discuss available IOL delivery systems and their potential effect on the efficiency and safety of cataract surgery
    • Identify the advantages and disadvantages of current and emerging advanced technology IOLs and summarize the latest data on potential outcomes achieved with different IOL types
    • Develop personalized treatment plans and match the most appropriate IOL to each patient, based on their unique preferences, personality, and ocular characteristics

    • Accreditation

      Provided by Evolve Medical Education 

      Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
      Evolve designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMEC®s) should contact the UEMS at mutualrecognition@uems.eu.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.

    • Faculty and Disclosures

      Blake K. Williamson, MD, MPH, MS

      Blake K. Williamson, MD, MPH, MS

      Managing Partner
      Williamson Eye Center and
      Outpatient Surgery Center for Sight
      Baton Rouge, LA


      Zaina Al-Mohtaseb, MD

      Zaina Al-Mohtaseb, MD

      Whitsett Vision Group
      Cataract, Refractive, & Cornea Surgeon

      Director of Research
      Clinical Associate Professor, Baylor College of Medicine
      Houston, TX


      Michael Greenwood, MD

      Michael Greenwood, MD

      Cataract, Refractive, Cornea, and Glaucoma Surgeon
      Vance Thompson Vision
      Fargo, ND


      Bennett Walton, MD, MBA

      Bennett Walton, MD, MBA

      Bennett Walton Vision
      Houston, TX


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Blake K. Williamson, MD, MPH, MS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Bausch + Lomb, BioTissue, Carl Zeiss Meditec, Diopsys, Eyevance, Glaukos, Johnson & Johnson Vision, New World Medical, Omeros, Shire, Sight Sciences, and Sun Pharma. Speaker’s Bureau: AbbVie, Allergan, Glaukos, New World Medical, and TearLab.

      Zaina Al-Mohtaseb, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant/Speaker's Bureau: Alcon, Allergan, Bausch + Lomb, BVI, Carl Zeiss Meditec, CorneaGen, Dompé, Johnson & Johnson, Kala Pharmaceuticals, Ocular Therapeutix, Tarsus Pharmaceuticals, Trefoil, Vista, and Visus.

      Michael Greenwood, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Aerie Pharmaceuticals, Allergan, BVI, Carl Zeiss Meditec, Equinox, Imprimis, Ivantis, New World Medical, Nevakar, and Ocular Therapeutix. Grant/Research Support: Alcon, Glaukos, Ocular Therapeutix, Sight Sciences, and STAAR Surgical. Speaker’s Bureau: Aerie Pharmaceuticals, Alcon, Allergan, Carl Zeiss Meditec, Equinox, Glaukos, Imprimis, Johnson & Johnson Vision, New World Medical, Ocular Therapeutix, Sight Sciences, STAAR Surgical, and Valeant. Stock/Shareholder: Equinox.

      Bennett Walton, MD, MBA, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie, Alcon, Allergan, Bausch + Lomb, BVI, Bruder Healthcare Company, Carl Ziess Meditec, Lensar, RxSight, STAAR Surgical, and Tarsus Pharmaceuticals. Grant/Research Support: Alcon, Avedro, BVI, Lensar, and RxSight. Speaker's Bureau: Alcon, Carl Zeiss Meditec, and STAAR Surgical.

      The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Alcon.

      This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    LIVE ON REACHMD RADIOBack to live radio
    ReachMD Radio

    Loading...

    00:00
    00:00
      Register

      We're glad to see you're enjoying Evolve Medical Education…
      but how about a more personalized experience?

      Register for free